XML 26 R34.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Common Stock, Stock Options and Warrants (Details Textual) |  |  |  |  | 1 Months Ended | 12 Months Ended |  |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Aug. 08, 2017 USD ($) $ / shares shares | Jun. 08, 2017 $ / shares shares | Apr. 07, 2017 $ / shares shares | Jan. 02, 2017 Consultants $ / shares shares | Sep. 27, 2019 | Sep. 16, 2019 USD ($) shares | Apr. 03, 2019 USD ($) $ / shares shares | Feb. 13, 2019 USD ($) shares | Sep. 30, 2018 USD ($) $ / shares shares | Aug. 13, 2018 | Apr. 02, 2018 USD ($) shares | Mar. 29, 2018 USD ($) $ / shares shares | Feb. 07, 2018 USD ($) Consultants shares | Dec. 19, 2017 USD ($) $ / shares shares | Nov. 07, 2017 USD ($) shares | Jun. 29, 2017 $ / shares shares | Feb. 28, 2017 USD ($) $ / shares shares | Feb. 28, 2017 USD ($) shares | Sep. 30, 2019 USD ($) Consultants $ / shares shares | Sep. 30, 2018 USD ($) Consultants $ / shares shares | Sep. 30, 2017 USD ($) Consultants $ / shares shares | Sep. 30, 2016 USD ($) | Jun. 07, 2017 USD ($) shares | May 05, 2017 USD ($) shares | Jan. 31, 2017 shares | Jun. 01, 2015 $ / shares | Apr. 01, 2015 $ / shares | Sep. 12, 2014 shares
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description of reverse stock split |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1-for-15 |  |  |  |  |  |
Common stock, shares issued | shares |  |  |  |  |  |  |  |  | 16,198,791 |  |  |  |  |  |  |  |  |  | 28,930,493 | 16,198,791 | 8,345,844 |  |  |  |  |  |  |
Common stock value | $ |  |  |  |  |  |  |  |  | $ 16,199 |  |  |  |  |  |  |  |  |  | $ 28,930 | $ 16,199 | $ 8,346 |  |  |  |  |  |  |
Stock-based compensation | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 715,983 | $ 779,701 | $ 986,620 |  |  |  |  |  |  |
Proceeds for research and development | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 741,843 |  |  |  |  |  |  |  |  |
Additional warrant purchase | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 12,802 |  |  |  |  |  |  |  |  |  |  |
Number of additional units sold | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 128,017 |  |  |  |  |  |  |
Number of unit offering per share price | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 6.00 |  |  |  |  |  |  |
Warrant issued to placement agent | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 58,759 |  |  |  |  |  |  |  |  |  |  |
Warrants issue | shares |  | 140,819 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of warrants recorded as derivative warrant liability | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 641,385 |  |  |  |  |  |  |
Stock issued for services and settlements | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 491,351 |  |  |  |  |  |  |
Common stock, par value | $ / shares |  |  |  |  |  |  |  |  | $ 0.001 |  |  |  |  |  |  |  |  |  | $ 0.001 | $ 0.001 | $ 0.001 |  |  |  |  |  |  |
Fees and commissions | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 90,000 | $ 75,000 | $ 50,000 |  |  |  |  |  |  |
Stock option purchase grants | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,090,799 |  |  |  |  |  |  |  |  |
Stock option average vest term |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 years 3 months 19 days |  |  |  |  |  |  |  |
Prepaid expenses | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ (9,621) | $ (162,514) | (572,098) |  |  |  |  |  |  |
Warrants sold and issued to investors | $ |  |  |  |  |  |  |  |  | $ 10,000 |  |  |  |  |  |  |  |  |  |  | 10,000 |  |  |  |  |  |  |  |
Common stock issued for services fair value | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 211,597 |  | 704,019 |  |  |  |  |  |  |
Other expense | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 75,000 | 50,000 | $ 45,000 |  |  |  |  |  |
Description of warrants |  |  |  |  | (i) 6,760,615 units, each unit consisting of one share of common stock and one immediately exercisable five-year warrant to purchase one share at $0.77 per share, and (ii) 1,060,615 pre-funded units, each pre-funded unit consisting of one pre-funded warrant to purchase one share and one immediately exercisable five-year warrant to purchase one share at $0.77 per share. The pre-funded warrants included in the pre-funded units are immediately exercisable at a price of $0.0001 per share and do not expire. The offering price was $0.8951 per unit and $0.895 per pre-funded unit. The net proceeds of the offering were $6,290,335. The Company issued the underwriter immediately exercisable five-year warrants to purchase up to 547,486 shares at $1.118875 per share with an estimated fair value of $323,414. The estimated fair value of the 1,060,615 pre-funded warrants was $809,145, and the estimated fair value of the 7,821,230 warrants included in the units and the pre-funded units issued to the investors was $4,845,341. |  |  |  |  | (i) 5,521,569 units, each unit consisting of one share of common stock and one immediately exercisable five-year warrant to purchase one share at $1.15 per share, and (ii) 2,321,569 pre-funded units, each pre-funded unit consisting of one pre-funded warrant to purchase one share and one immediately exercisable five-year warrant to purchase one share at $1.15 per share. The pre-funded warrants included in the pre-funded units are immediately exercisable at a price of $0.01 per share and do not expire. The offering price was $1.275 per unit and $1.265 per pre-funded unit. The net proceeds of the offering were $8,926,786. The Company issued underwriter warrants to purchase up to 549,020 shares at $1.59375 per share with an estimated fair value of $491,737. The underwriter warrants are exercisable following February 8, 2019 and expire on August 8, 2023. The estimated fair value of the 2,321,569 pre-funded warrants was $2,630,072, and the estimated fair value of the 7,843,138 warrants included in the units and the pre-funded units issued to the investors was $7,311,727. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from common stock warrant exercises | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 23,216 | $ 1,125,148 |  |  |  |  |  |  |  |
Weighted average period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 year 7 months 28 days |  |  |  |  |  |  |  |  |
weighted average remaining life of all of the outstanding warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3 years 7 months 17 days |  |  |  |  |  |  |  |  |
Aggregate intrinsic value for the warrants outstanding | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 805,961 |  |  |  |  |  |  |  |  |
Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1.27 |  |  |  |  |  |  |  |  |
Minimum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.94 |  |  |  |  |  |  |  |  |
2017 Public Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock issued for services | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 100,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock issued for services fair value | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 60,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Underwriter payment, restricted common stock fair value | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 257,400 |  |  |  |  |  |  |  |  |  |  |  |  |
Other expense | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 357,400 |  |  |  |  |  |  |  |  |  |  |  |  |
Registered Direct and Private Placement Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  |  |  |  |  |  | $ 1.42 |  |  |  |  |  |  | $ 2.86 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants sold and issued to investors | $ |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 420,566 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued | shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 89,625 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of offering fee |  |  |  |  |  |  |  |  |  |  |  |  |  | 7.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock Options [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock outstanding | shares |  |  |  |  |  |  |  |  | 1,601,039 |  |  |  |  |  |  |  |  |  | 1,771,039 | 1,601,039 |  |  |  |  |  |  |  |
Weighted-average remaining contractual term, exercisable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 7 years 1 month 9 days |  |  |  |  |  |  |  |  |
Stock options to purchase exercised | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate intrinsic value for the warrants outstanding | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 49,465 |  |  |  |  |  |  |  |  |
Share-based payment award, description |  |  |  |  |  |  |  |  | In September 2018, the Board of Directors granted stock options to purchase a total of 520,000 shares to six employees, 75,000 options to five directors, and 80,000 options to three consultants at $1.62 per share. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Omnibus Stock Incentive Plan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares issued | shares |  |  |  |  |  |  |  |  |  |  |  |  | 2,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock option purchase grants | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,085,000 |  |  |  |  |  |  |  |  |
Financial advisor warrants exercised | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 915,000 |  |  |  |  |  |  |  |  |
Private Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Settlement expense | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 161,771 |  |  |  |  |  |  |
Issuance of common stock in private placement, net of costs, shares | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 58,191 |  |  |  |  |  |  |
Stock Options [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options to purchase exercised | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase Options Units [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other expense | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 96,930 | $ 96,930 |  |  |  |  |  |  |
Employee [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options to purchase exercised | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 165,000 |  |  |  |  |  |  |  |  |
Stock option estimated fair value, shares | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.94 |  |  |  |  |  |  |  |  |
Accredited Investors [Member] | Registered Direct and Private Placement Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of units sold | shares |  |  |  |  |  |  |  |  |  |  |  | 669,504 |  | 1,280,360 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 4.6925 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants sold and issued to investors | $ |  |  |  |  |  |  | $ 5,300,001 |  |  |  |  | $ 1,998,469 |  | $ 6,008,089 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of common stock | shares |  |  |  |  |  |  |  |  |  |  |  | 669,504 |  | 1,280,360 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investor [Member] | Registered Direct and Private Placement Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of units sold | shares |  |  |  |  |  |  | 3,430,421 |  |  |  |  | 669,504 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 5.8656 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Amendements to fair value of warrants | $ |  |  |  |  |  |  | $ 3,430,421 |  |  |  |  | $ 669,504 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants sold and issued to investors | $ |  |  |  |  |  |  | $ 2,709,467 |  |  |  |  | $ 1,679,482 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of common stock | shares |  |  |  |  |  |  | 3,430,421 |  |  |  |  | 669,504 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  | The Company sold the investors 640,180 immediately exercisable five and a half year warrants at $4.63 per share. |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued | shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 640,180 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Estimated fair value of the warrant granted to the placement agent | $ |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 2,407,276 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Placement Agent [Member] | Registered Direct and Private Placement Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of units sold | shares |  |  |  |  |  |  | 3,430,421 |  |  |  |  | 669,504 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of units sold for gross proceeds | $ |  |  |  |  |  |  |  |  |  |  |  | $ 46,866 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of stock price | $ / shares |  |  |  |  |  |  | $ 1.545 |  |  |  |  | $ 2.985 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other cash expenses related to placements | $ |  |  |  |  |  |  | $ 85,000 |  |  |  |  | $ 85,000 |  | 85,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants sold and issued to investors | $ |  |  |  |  |  |  | 169,854 |  |  |  |  | 110,511 |  | 5,482,523 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other expense | $ |  |  |  |  |  |  | $ 10,000 |  |  |  |  | $ 10,000 |  | $ 20,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of common stock | shares |  |  |  |  |  |  | 3,430,421 |  |  |  |  | 669,504 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description of warrants |  |  |  |  |  |  | The Company paid the placement agent a fee of 7% of the gross proceeds totaling $371,000 and issued the placement agent 240,130 immediately exercisable two-year warrants with an exercise price of $1.93125 per share. |  |  |  |  | The Company paid the placement agent a fee of 7% of the gross proceeds totaling $139,893 and issued the placement agent 46,866 immediately exercisable five-year warrants at $3.73125 per share. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued | shares |  |  |  |  |  |  | 240,130 |  |  |  |  | 46,866 |  | 89,625 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of offering fee |  |  |  |  |  |  | 7.00% |  |  |  |  | 7.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrants |  |  |  |  |  |  | 2 years |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Estimated fair value of the warrant granted to the placement agent | $ |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 316,071 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from common stock warrant exercises | $ |  |  |  |  |  |  | $ 4,834,001 |  |  |  |  | $ 1,763,576 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Executive Chairman [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock exercise price per share | $ / shares |  |  |  | $ 10.05 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 3.45 |  |  |  |  |  |  |
Stock options to purchase exercised | shares |  |  |  | 8,669 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25,000 | 520,000 | 225,000 |  |  |  |  |  |  |
Stock option purchase grants | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 80,000 | 50,000 |  |  |  |  |  |  |
Weighted average grant-date estimated per share | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1.75 |  |  |  |  |  |  |  |
Stock option average vest term |  |  |  | 10 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 10 years | 10 years | 10 years |  |  |  |  |  |  |
Stock option estimated fair value, shares | shares |  |  |  | 8.41 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1.04 | 1.45 | 2.95 |  |  |  |  |  |  |
Number of consultants | Consultants |  |  |  | 4 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4 | 3 | 2 |  |  |  |  |  |  |
Options vest, description |  |  |  | These options vest over terms of 12 to 36 months and have a term of 10 years. |  |  |  |  |  |  |  |  |  |  |  |  |  |  | These options vest over terms of 12 to 36 months and have a term of 10 years. | These options vest over terms of 12 to 36 months and have a term of 10 years. | These options vest over terms of 12 to 36 months and have a term of 10 years. |  |  |  |  |  |  |
Executive Chairman [Member] | Stock Options [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock exercise price per share | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 9.00 | $ 9.00 |
Leonard Meron Biosciences [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares issued | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 11,400 |  |  |  |
Common stock value | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 77,748 |  |  |  |
Settlement expense | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 77,748 |  |  |  |  |  |  |
Financial Consultant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options to purchase exercised | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 70,000 |  |  |  |  |  |  |  |
Purchase Options Units [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock exercise price per share | $ / shares |  |  | $ 9.00 |  |  |  |  |  |  |  |  |  |  |  |  | $ 9.00 |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding purchase of common stock, shares | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 193,860 |  |  |  |  | 104,138 |  |  |  |  |  |  |
Number of unit purchase | shares |  |  | 38,000 |  |  |  |  |  |  |  |  |  |  |  |  | 62,667 |  |  |  |  |  |  |  |  |  |  |  |
Number of units purchase, per unit | $ / shares |  |  | $ 9.00 |  |  |  |  |  |  |  |  |  |  |  |  | $ 9.00 |  |  |  |  |  |  |  |  |  |  |  |
Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares issued | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 866,667
Stock-based compensation | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock issued for services and settlements | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 128 |  |  |  |  |  |  |
Issuance of common stock in private placement, net of costs, shares | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 128,016 |  |  |  |  |  |  |
Stock options to purchase exercised | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4,829 |  |  |  |  |  |  |
Stock option purchase grants | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,799 |  |  |  |  |  |  |  |
Number of consultants | Consultants |  |  |  |  |  |  |  |  |  |  |  |  | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock issued for services | shares |  |  |  |  |  | 94,097 |  | 125,000 |  |  | 10,000 |  | 22,200 |  |  |  |  |  | 219,097 |  | 140,843 |  |  |  |  |  |  |
Common stock issued for services fair value | $ |  |  |  |  |  | $ 94,097 |  | $ 117,500 |  |  | $ 31,000 |  | $ 88,800 |  |  |  |  |  | $ 219 |  | $ 141 |  |  |  |  |  |  |
Financial advisor warrants exercised | shares |  |  |  |  |  |  |  |  | 4,829 |  |  |  |  |  |  |  |  |  |  | 4,829 |  |  |  |  |  |  |  |
Retained Earnings [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock issued for services and settlements | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock issued for services fair value | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Additional Paid-in Capital [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 715,983 | $ 779,701 | 986,620 |  |  |  |  |  |  |
Stock issued for services and settlements | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 491,223 |  |  |  |  |  |  |
Common stock issued for services fair value | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 211,378 |  | 703,878 |  |  |  |  |  |  |
Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock issued for services and settlements | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options to purchase exercised | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock issued for services | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock issued for services fair value | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of outstanding warrants | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 25,492,513 |  |  |  |  |  |  |  |  |
2017 Public Offering and Release Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of unit offering per share price | $ / shares | $ 4.125 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares | $ 4.125 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share issued | shares | 1,648,484 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted-average remaining contractual term, exercisable | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants to purchase | shares | 1,648,484 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants to purchase of common stock price per share | $ / shares | $ 0.01 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
2017 Public Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock in private placement, net of costs, shares | shares | 58,191 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, par value | $ / shares | $ 4.125 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
2017 Public Offering [Member] | Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock sold for gross proceeds | $ | $ 6,802,469 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Unit purchase options, description | The Company granted the underwriters a 45-day option to purchase up to an additional 247,272 shares of common stock and warrants to purchase 247,272 shares of common stock to cover over-allotments, if any. On August 8, 2017, the underwriters partially exercised the over-allotment to purchase an additional 247,272 warrants. The estimated fair value of the 1,895,756 warrants issued to the investors was $4,160,195 and the estimated fair value of the 65,940 warrants issued to the underwriters was $142,419. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, par value | $ / shares | $ 4.125 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fees and commissions | $ | $ 685,573 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted-average remaining contractual term, exercisable | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investor Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares issued | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 29,729 |  |  |
Warrants issue | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 128,017 | 128,017 |  |  |  |  |  |  |  |  |  |
Fair value of common stock | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 587,592 |  |  | 298,774 |  |  |  |  |  |  |
Common stock outstanding | shares |  |  |  |  |  |  |  |  | 202,469 |  |  |  |  |  |  |  |  |  |  | 202,469 |  |  |  |  |  |  |  |
Stock option estimated fair value | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 4,160,195 |  |  |  |  |  |  |
Stock option estimated fair value, shares | shares | 1,895,756 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Offering Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding purchase of common stock, shares | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 12,802 |  |  |  |  |  |  |
Additional warrant purchase | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 12,802 |  |  |  | 12,802 |  |  |  |  |  |  |
Number of units sold | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 128,017 |  |  |  |  |  |  |  |  |  |  |
Number of units sold, per unit | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 6.00 |  |  |  |  |  |  |  |  |  |  |
Number of units sold for gross proceeds | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 768,100 |  |  |  |  |  |  |  |  |  |  |
Expense allowance, percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3.00% |  |  |  |  |  |  |  |  |  |  |
Percentage of cash commission on gross proceeds |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 10.00% |  |  |  |  |  |  |  |  |  |  |
Warrants issue | shares |  |  |  |  |  |  |  |  | 272,767 |  |  |  |  |  |  |  |  |  |  | 272,767 |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  | $ 4.125 |  |  |  |  |  |  | $ 4.25 |  |  |  |  |  |  |  |  |  |  | $ 4.25 |  |  |  |  |  |  |  |
Sale of common stock | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 128,017 |  |  |  |  |  |  |  |  |  |  |
Proceeds from common stock warrant exercises | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,125,148 |  |  |  |  |  |  |  |
Placement Agent Unit Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of units sold | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 128,017 |  |  |  |  |  |  |  |  |  |  |
Expense allowance | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 99,853 |  |  |  |  |  |  |  |  |  |  |
Warrant offering description |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | The Company sold 128,017 units at $6.00 per unit for gross proceeds of $768,100. Each unit consisted of (i) one share of common stock and (ii) a five-year warrant to purchase one share of common stock at an exercise price of $8.25 per share. The placement agent received a 10% cash commission on the gross proceeds, an expense allowance equal to 3% of the proceeds, and warrants to purchase 12,802 shares of common stock at an exercise price of $8.25 per share. The estimated fair value of the 128,017 warrants issued to the investors was $587,592 and the estimated fair value of the 12,802 warrants issued to the placement agent was $58,759. The placement agent commissions and expense allowance was $99,853. Other costs of the placement were $176,896. |  |  |  |  |  |  |  |  |  |  |
Warrants issue | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 12,802 |  |  |  |  |  |  |
Fair value of common stock | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 587,592 |  |  |  |  |  |  |  |  |  |  |
Other cost | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 176,896 |  |  |  |  |  |  |  |  |  |  |
Sale of common stock | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 128,017 |  |  |  |  |  |  |  |  |  |  |
Underwriters [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock option estimated fair value | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 142,419 |  |  |  |  |  |  |
Stock option estimated fair value, shares | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 65,940 |  |  |  |  |  |  |
Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares issued | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6,668 |  |  |  |  |
Common stock value | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 45,476 |  |  |  |  |
Settlement expense | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 45,476 |  |  |  |  |  |  |
Description of release agreements |  | In exchange, the Company agreed that (i) in the event that a financing is conducted at a price per share or price per unit lower than $6.00, then the Company will issue additional shares to each investor sufficient to effectively reprice the sale of the 2016 Offering units to the lower price; (ii) in the event that the financing is conducted at a price per share or price per unit less than the $8.25 exercise price of the warrants issued in the 2016 Offering then the exercise price of the warrants shall be reduced to the lower price; and (iii) the Company will give each investor no less than 6 hours of notice before the closing of any subsequent financing, through and including the Company's 2017 registered public offering, and each investor shall have a 6-hour option to purchase up to 20% of the securities sold in such offering. In connection with these agreements the Company reclassified the $641,385 fair value of the 140,819 warrants issued in the 2016 Offering to derivative warrant liability on June 8, 2017. On August 8, 2017, the Company completed its 2017 public offering and issued 58,191 shares of common stock to the investors in the 2016 Offering to reprice the sale of the 2016 Offering units to $4.125 per unit and repriced the 2016 Offering Warrants to an exercise price of $4.125 per share. During the year ended September 30, 2017, the Company recorded a settlement expense of $161,771 in connection with the issuance of the additional 58,191 shares of common stock and reclassified the current fair value of the warrants to additional paid-in capital. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding purchase of common stock, shares | shares |  | 140,819 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares | $ 4.125 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Offering pre-Funded [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants issue | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,321,569 |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.01 |  |  |  |  |  |  |  |  |
Proceeds from common stock warrant exercises | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 23,216 |  |  |  |  |  |  |  |  |

X
- Definition Additional warrant purchase. + References No definition available. + Details
Name: | ctxr_AdditionalWarrantPurchase
Namespace Prefix: | ctxr_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of amendments of fair value of warrants. + References No definition available. + Details
Name: | ctxr_AmendementsToFairValueOfWarrants
Namespace Prefix: | ctxr_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | ctxr_CommonStockAndStockOptionsAndWarrantsTextualAbstract
Namespace Prefix: | ctxr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Explanation of release agreements. + References No definition available. + Details
Name: | ctxr_DescriptionOfReleaseAgreements
Namespace Prefix: | ctxr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Expense allowance. + References No definition available. + Details
Name: | ctxr_ExpenseAllowance
Namespace Prefix: | ctxr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Expense allowance percentage. + References No definition available. + Details
Name: | ctxr_ExpenseAllowancePercentage
Namespace Prefix: | ctxr_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of fair value of common stock. + References No definition available. + Details
Name: | ctxr_FairValueOfCommonStock
Namespace Prefix: | ctxr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Fair value of warrants recorded as derivative warrant liability. + References No definition available. + Details
Name: | ctxr_FairValueOfWarrantsRecordedAsDerivativeWarrantLiability
Namespace Prefix: | ctxr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of additional units sold. + References No definition available. + Details
Name: | ctxr_NumberOfAdditionalUnitSold
Namespace Prefix: | ctxr_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of consultants. + References No definition available. + Details
Name: | ctxr_NumberOfConsultants
Namespace Prefix: | ctxr_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of unit offering price per share. + References No definition available. + Details
Name: | ctxr_NumberOfUnitOfferingPerSharePrice
Namespace Prefix: | ctxr_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of unit purchase per share. + References No definition available. + Details
Name: | ctxr_NumberOfUnitPurchase
Namespace Prefix: | ctxr_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of unit purchase per unit. + References No definition available. + Details
Name: | ctxr_NumberOfUnitsPurchasePerUnit
Namespace Prefix: | ctxr_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash inflow from number of units sold for gross proceeds. + References No definition available. + Details
Name: | ctxr_NumberOfUnitsSoldForGrossProceeds
Namespace Prefix: | ctxr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The number of units sold per share. + References No definition available. + Details
Name: | ctxr_NumberOfUnitsSoldPerUnit
Namespace Prefix: | ctxr_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ctxr_OtherCostOfService
Namespace Prefix: | ctxr_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Percentage of cash commission on gross proceeds. + References No definition available. + Details
Name: | ctxr_PercentageOfCashCommissionOnGrossProceeds
Namespace Prefix: | ctxr_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Its represented percentage of offering fee. + References No definition available. + Details
Name: | ctxr_PercentageOfOfferingFee
Namespace Prefix: | ctxr_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of settlement expense. + References No definition available. + Details
Name: | ctxr_SettlementExpense
Namespace Prefix: | ctxr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition It represent stock option estimated fair value. + References No definition available. + Details
Name: | ctxr_SharesBasedCompensationStockOptionEstimatedFairValue
Namespace Prefix: | ctxr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Stock sold for gross proceeds. + References No definition available. + Details
Name: | ctxr_StockSoldForGrossProceeds
Namespace Prefix: | ctxr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Term of warrants. + References No definition available. + Details
Name: | ctxr_TermOfWarrants
Namespace Prefix: | ctxr_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Its represented underwriters amount. + References No definition available. + Details
Name: | ctxr_UnderwriterAmount
Namespace Prefix: | ctxr_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Unit purchase options description. + References No definition available. + Details
Name: | ctxr_UnitPurchaseOptionsDescription
Namespace Prefix: | ctxr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of warrants issued to the placement agent. + References No definition available. + Details
Name: | ctxr_WarrantIssuedToPlacementAgent
Namespace Prefix: | ctxr_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Description of warrant offering. + References No definition available. + Details
Name: | ctxr_WarrantOfferingDescription
Namespace Prefix: | ctxr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of warrants issued. + References No definition available. + Details
Name: | ctxr_WarrantsIssued
Namespace Prefix: | ctxr_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Outstanding warrants to purchase of its common stock. + References No definition available. + Details
Name: | ctxr_WarrantsOutstandingPurchaseOfCommonStock
Namespace Prefix: | ctxr_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | ctxr_WarrantsToPurchaseOfCommonStockPricePerShare
Namespace Prefix: | ctxr_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition It represent warrants to purchase shares. + References No definition available. + Details
Name: | ctxr_WarrantsToPurchaseShares
Namespace Prefix: | ctxr_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ctxr_WeightedAverageRemainingLifeOfOutstandingWarrants
Namespace Prefix: | ctxr_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Adjustment for noncash service expenses paid for by granting of warrants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585 + Details
Name: | us-gaap_AdjustmentOfWarrantsGrantedForServices
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(4)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(2)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition This item provides the title of issue of securities called for by warrants or rights outstanding. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(1)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of warrants or rights which entitle the entity to receive future services in exchange for the unvested, forfeitable warrants or rights. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 + Details
Name: | us-gaap_ClassOfWarrantOrRightUnissued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2(a),(d)) -URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227 + Details
Name: | us-gaap_CostOfGoodsAndServicesSold
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 + Details
Name: | us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585 + Details
Name: | us-gaap_IncreaseDecreaseInPrepaidExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow associated with the repurchase of amount received from entity's raising of capital via private rather than public placement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585 + Details
Name: | us-gaap_PaymentsForRepurchaseOfPrivatePlacement
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromIssuanceOfWarrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromWarrantExercises
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. + References No definition available. + Details
Name: | us-gaap_ResearchAndDevelopmentInProcess
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045 + Details
Name: | us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of noncash expense for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585 + Details
Name: | us-gaap_ShareBasedCompensation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Net number of non-option equity instruments granted to participants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(1) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of options outstanding, including both vested and non-vested options. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i)-(ii) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares issued under share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(1) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average grant-date fair value of options vested. + References No definition available. + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. + References No definition available. + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesIssuedForServices
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares of stock issued attributable to transactions classified as other. + References No definition available. + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesOther
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of share options (or share units) exercised during the current period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(2) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. + References No definition available. + Details
Name: | us-gaap_StockIssuedDuringPeriodValueIssuedForServices
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodValueNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 4 -Subparagraph (SAB Topic 4.C) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770 + Details
Name: | us-gaap_StockholdersEquityReverseStockSplit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_WarrantsAndRightsOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=ctxr_TwoZeroOneSevenPublicOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=ctxr_RegisteredDirectAndPrivatePlacementOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_StockOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=ctxr_OmnibusStockIncentivePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_StockOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=ctxr_PurchaseOptionsUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=ctxr_EmployeeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=ctxr_AccreditedInvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=us-gaap_InvestorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=ctxr_PlacementAgentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=ctxr_LeonardMeronBiosciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=ctxr_FinancialConsultantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=ctxr_PurchaseOptionsUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=ctxr_TwoThousandSeventeenPublicOfferingAndReleaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=ctxr_TwoZeroOneSevenPublicOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=ctxr_InvestorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=ctxr_OfferingWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=ctxr_PlacementAgentUnitWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=ctxr_UnderwritersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=ctxr_OfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=ctxr_OfferingPreFundedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |